Moreover, the elevated expression level of TPD52 noticeably inhibited the proliferation, migration, and invasion of renal cell carcinoma cells, as well as decreased tumor progression in renal carcinoma xenografts [20]. This evidence concerns the gene TPD52 and renal carcinoma.